EPAS1 and cardiomyopathy: Together, these findings highlight the potential of spatial transcriptomics as a powerful tool for linking molecular processes to local remodeling responses and indicate EPAS1 as a critical molecular driver of cardiomyocyte degeneration in the context of DSP-cardiomyopathy.